0001209191-14-018970.txt : 20140310
0001209191-14-018970.hdr.sgml : 20140310
20140310172707
ACCESSION NUMBER: 0001209191-14-018970
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140306
FILED AS OF DATE: 20140310
DATE AS OF CHANGE: 20140310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVITT DANIEL J
CENTRAL INDEX KEY: 0001278711
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 14682047
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORP
STREET 2: 2929 SEVENTH ST STE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-03-06
0
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0001278711
LEVITT DANIEL J
C/O AQUINOX PHARMACEUTICALS, INC.
450 - 887 GREAT NORTHERN WAY
VANCOUVER
A1
V5T 4T5
BRITISH COLUMBIA, CANADA
1
0
0
0
Stock Option (Right to Buy)
11.00
2014-03-06
4
A
0
8333
0.00
A
2024-03-05
Common Stock
8333
20051
D
The shares subject to this option shall vest in equal annual installments, at a rate of 1/3rd of the total number of shares on the one-year anniversary of the grant date, 1/3rd of the total number of shares on the second-year anniversary of the grant date, and 1/3rd of the total number of shares on the third-year anniversary of the grant date.
Includes (i) 8,333 shares issuable upon exercise of an option grant pursuant to the issuer's 2014 Equity Incentive Plan (the "2014 Plan") and (ii) 11,718 option securities issuable upon exercise of an option granted pursuant to the issuer's Joint Canadian Stock Option Plan (the "2006 Plan"). Each option under the 2014 Plan is exercisable for shares of common stock. Each option security granted under the 2006 Plan is exercisable for an "option security". Prior to the closing of the issuer's initial public offering, an option security is comprised of one common exchangeable share and one special voting share of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act. Following the closing of the issuer's initial public offering, an option security will be comprised of one share of the issuer's common stock.
/s/ Daniel Levitt
2014-03-10